GLP-1s: Gut issues & autoimmunity?

The anti-inflammatory mechanism of GLP-1 affecting multiple autoimmune conditions simultaneously is the clinical picture that makes the most sense - the pathway modulation is not condition-specific and can affect several inflammatory processes in parallel. Multi-condition improvement is one of the better arguments for treating the metabolic root rather than each condition separately.

The post-norovirus gut inflammation causing temporary lactose intolerance and IBS-like symptoms is a real and recognized phenomenon - the intestinal lining takes time to restore the enzyme density and microbiome balance after a significant viral insult. Running GLP-1 during that recovery phase adds slowed motility on top of gut lining that's already fragile, which can amplify both the constipation and the sensitivity responses.